cx r22 2 45
219067783
http://www.idref.fr/219067783
20171022
20220915014434.000
0499
0499
Tr2
20171022afrey50 ba0
eng
2008
u
fre
0
#
#
AFNOR
Oeuvre Textuelle
ba0yba0
Pharmacotherapy of Obesity
ba0yba0y
Obesity has become a major epidemic that now rivals smoking as a risk to public health. The ensuing epidemics of diabetes, vascular disease and other complications are set to overwhelm the healthcare systems of wealthy and poorer nations alike. The need for effective pharmacotherapy has never been greater. This book takes a new look at the many potential targets for drug development for regulation of body weight, placing them in the context of the chequered history of drug development for obesity and currently available therapies. Potential peripheral and central nervous system targets are discussed in detail by authors with extensive knowledge and research experience in the science of body weight regulation, and its translation into effective therapies that will benefit patients. This book is of interest to clinicians, researchers in the field and members of the pharmaceutical industry who are interested in learning more about the current state of the art and future directions in the pharmacotherapy of obesity.
ba0yba02
Wilding
John P. H.
070
Medicine
lc
Toxicology
lc
Biomedicine
lc
Cardiology
lc
Cell Biology
lc
Diabetes
lc
Metabolic Diseases
lc
Pharmacology/Toxicology
lc
Cardiology
lc
Cell biology
lc
Diabetes
lc
Metabolic diseases
lc
Pharmacology
lc
Obesity
Chemotherapy
lc
027243834
Obésité
027413756
Chimiothérapie
rameau
Obesity
drug therapy
mesh
Pharmacology/Toxicology
Metabolic Diseases
Diabetes
Cardiology
Cell Biology
FR
Abes
20220915
AFNOR